BibTex RIS Kaynak Göster

Etanercept protects remote organ damage in a rat model of thermal injury

Yıl 2011, Cilt: 15 Sayı: 3, 118 - 124, 07.03.2014

Öz

Kaynakça

  • Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns 2008;34:6-17.
  • Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 1993;121:328-36.
  • Kataranovski M, Magić Z, Pejnović N. Early inflammato- ry cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res 1999;48:473- 82.
  • Yamashita Y, Jeschke MG, Wolf SE. Differential expres- sion of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in rats. Cytokine 2000;12:1293-8.
  • Meakins JL. Etiology of multiple organ failure. J Trauma 1990;30:S165–8.
  • Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998;10:79–89).
  • Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KA, Banerjee A, et al. Tumor necrosis factor-a and inter- leukin-1b synergistically depress human myocardial function. Crit Care Med 1999;27: 1309-18.
  • Giroir B, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994; 267: H118-24.
  • Taylor PC. Pharmacology of TNF blockade in rheuma- toid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol 2010;10:308-15.
  • Goldenberg MM. Etanercept, a novel drug for the treat- ment of patients with severe, active rheumatoid arthritis. Clin Ther 1999;21:75-87.
  • Martinek RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 1972;40:91–9.
  • Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–11.
  • B eutler E. Glutathione. In: Red blood cell metabolism. A Manuel of Biochemical Methods, Grune and Stratton, New York, NY.1975:112–14.
  • Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Der- matol 1982;78:206-9.
  • Hillega ss LM, Griswold DE, Brickson B, Albrightson- Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285-95.
  • K im YK, Lee SH, Goldinger JM, Hong SK. Effect of eth- anol on organic ion transport in rabbit kidney. Toxicol Appl Pharmacol 1986;86:411-20.
  • Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol Cogn Med Sci 1980;65:105-16.
  • F iske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375–400.
  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Pro- tein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
  • Teodorczyk-Injeyan J A, Sparkes B G, Mills G B, Peters W J, Falk R E. Impairment of T cell activation in burn pa- tients: a possible mechanism of thermal injury induced immunosuppression. Clin Exp Immunol 1986;65:570-81.
  • Pruitt B A. Jr. Infection and the burn patient. Br JSurg 1990;77, 1081-2.
  • O’Sullivan ST, O’Connor T P Immunosuppression fol- lowing thermal injury: the pathogenesis of immunodys- function. Br J Plast Surg 1997; 50: 615-23.
  • Horton JW. Free radicals and lipid peroxidation mediat- ed injury in burn trauma: the role of antioxidant therapy. Toxicology 2003;189:75–88.
  • Ravage ZB, Gomez HF, Czermak BJ, Watkins SA, Till GO. Mediators of microvascular injury in dermal burn wounds. Inflammation 1998;22:619-29.
  • Yeh FL, Lin WL, Shen HD. Changes in circulating lev- els of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 2000;26:454-9.
  • Wang G, Tian J, Tang H, Zhu S, Huan J, Ge S, Xia Z. (The role of Kupffer cells on the postburn production of TN- Falpha, IL-1beta and IL-6 in severely scalded rats). Zhon- ghua Shao Shang Za Zhi. 2002;18:282-4.
  • Toklu HZ, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, Sener, G. Silymarin, the antioxidant component of Si- lybum marianum, protects against burn induced oxida- tive skin injury. Burns 2007;33:908-16.
  • Reiter RJ , Tan DX, Manchester LC, Qi W. Biochemical re- activity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys 2001;34:237-56.
  • Yilmaz M, Topsakal S, Herek O, Ozmen O, Sahinduran S, Buyukoglu T, et al. Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats. Transl Res 2009;154:241-9.
  • Genovese T, Mazzon E, Crisafulli C, Esposito E, Di Paola R, Muià C, et al. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007;150:168-81.
  • Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC. Inhibition of TNF-alpha reduces myocar- dial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol 2006;48:320-8.
  • Sabry A, Wafa I, El-Din AB, El-Hadidy AM, Hassan M. Early markers of renal injury in predicting outcome in thermal burn patients. Saudi J Kidney Dis Transpl 2009;20:632-8.
  • Pintaudi AM, Tesoriere L, D’Arpa N, D’Amelio L, D’Arpa D, Bongiorno A, et al. Oxidative stress after moderate to extensive burning in humans. Free Radic Res. 2000;33:139-46.
  • Sener G, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yeğen BC. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 2005;31:587-96.
  • Sener G, Sehirli AO, Gedik N, Dülger GA. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns 2007;33:587-93.
  • Koksel O, Ozdulger A, Tamer L, Cinel L, Ercil M, De- girmenci U, et al. Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats. Pulm Pharmacol Ther 2006;19:90-5.
  • Koksel O, Kaplan MB, Ozdulger A, Tamer L, Degirmenci U, Cinel L, et al. Oleic acid-induced lung injury in rats and effects of caffeic acid phenethyl ester. Exp Lung Res 2005;31:483-96.
  • Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L, Araya J. Changes in (Na + K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxica- tion. Chest 2002;121:589-96.
  • Furst DE. Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis. Clin Exp Rheuma- tol 2010;28(3 Suppl 59):S5-12.
  • Di Paola R, Mazzon E, Muià C, Crisafulli C, Terrana D, Greco S, et al. Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol 2007;150:286-97.

of Pharmacy, Istanbul, Türkiye

Yıl 2011, Cilt: 15 Sayı: 3, 118 - 124, 07.03.2014

Öz

Kaynakça

  • Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stress and anti-oxidative mobilization in burn injury. Burns 2008;34:6-17.
  • Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 1993;121:328-36.
  • Kataranovski M, Magić Z, Pejnović N. Early inflammato- ry cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res 1999;48:473- 82.
  • Yamashita Y, Jeschke MG, Wolf SE. Differential expres- sion of hepatocyte growth factor in liver, kidney, lung, and spleen following burn in rats. Cytokine 2000;12:1293-8.
  • Meakins JL. Etiology of multiple organ failure. J Trauma 1990;30:S165–8.
  • Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998;10:79–89).
  • Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KA, Banerjee A, et al. Tumor necrosis factor-a and inter- leukin-1b synergistically depress human myocardial function. Crit Care Med 1999;27: 1309-18.
  • Giroir B, Horton JW, White DJ, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994; 267: H118-24.
  • Taylor PC. Pharmacology of TNF blockade in rheuma- toid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol 2010;10:308-15.
  • Goldenberg MM. Etanercept, a novel drug for the treat- ment of patients with severe, active rheumatoid arthritis. Clin Ther 1999;21:75-87.
  • Martinek RG. A rapid ultraviolent spectrophotomeetric lactic dehydrogenase assay. Clin Chem Acta 1972;40:91–9.
  • Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–11.
  • B eutler E. Glutathione. In: Red blood cell metabolism. A Manuel of Biochemical Methods, Grune and Stratton, New York, NY.1975:112–14.
  • Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Der- matol 1982;78:206-9.
  • Hillega ss LM, Griswold DE, Brickson B, Albrightson- Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990; 24: 285-95.
  • K im YK, Lee SH, Goldinger JM, Hong SK. Effect of eth- anol on organic ion transport in rabbit kidney. Toxicol Appl Pharmacol 1986;86:411-20.
  • Reading HW, Isbir T. The role of cation activated ATPase in transmitter release from the art iris. Q J Exp Physiol Cogn Med Sci 1980;65:105-16.
  • F iske CH, SubbaRow Y. The colorimetric determination of phosphorus. J Biol Chem 1925;66:375–400.
  • Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Pro- tein measurements with the folin phenol reagent. J Biol Chem 1951;193:265-75.
  • Teodorczyk-Injeyan J A, Sparkes B G, Mills G B, Peters W J, Falk R E. Impairment of T cell activation in burn pa- tients: a possible mechanism of thermal injury induced immunosuppression. Clin Exp Immunol 1986;65:570-81.
  • Pruitt B A. Jr. Infection and the burn patient. Br JSurg 1990;77, 1081-2.
  • O’Sullivan ST, O’Connor T P Immunosuppression fol- lowing thermal injury: the pathogenesis of immunodys- function. Br J Plast Surg 1997; 50: 615-23.
  • Horton JW. Free radicals and lipid peroxidation mediat- ed injury in burn trauma: the role of antioxidant therapy. Toxicology 2003;189:75–88.
  • Ravage ZB, Gomez HF, Czermak BJ, Watkins SA, Till GO. Mediators of microvascular injury in dermal burn wounds. Inflammation 1998;22:619-29.
  • Yeh FL, Lin WL, Shen HD. Changes in circulating lev- els of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 2000;26:454-9.
  • Wang G, Tian J, Tang H, Zhu S, Huan J, Ge S, Xia Z. (The role of Kupffer cells on the postburn production of TN- Falpha, IL-1beta and IL-6 in severely scalded rats). Zhon- ghua Shao Shang Za Zhi. 2002;18:282-4.
  • Toklu HZ, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, Sener, G. Silymarin, the antioxidant component of Si- lybum marianum, protects against burn induced oxida- tive skin injury. Burns 2007;33:908-16.
  • Reiter RJ , Tan DX, Manchester LC, Qi W. Biochemical re- activity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys 2001;34:237-56.
  • Yilmaz M, Topsakal S, Herek O, Ozmen O, Sahinduran S, Buyukoglu T, et al. Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats. Transl Res 2009;154:241-9.
  • Genovese T, Mazzon E, Crisafulli C, Esposito E, Di Paola R, Muià C, et al. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007;150:168-81.
  • Gu Q, Yang XP, Bonde P, DiPaula A, Fox-Talbot K, Becker LC. Inhibition of TNF-alpha reduces myocar- dial injury and proinflammatory pathways following ischemia-reperfusion in the dog. J Cardiovasc Pharmacol 2006;48:320-8.
  • Sabry A, Wafa I, El-Din AB, El-Hadidy AM, Hassan M. Early markers of renal injury in predicting outcome in thermal burn patients. Saudi J Kidney Dis Transpl 2009;20:632-8.
  • Pintaudi AM, Tesoriere L, D’Arpa N, D’Amelio L, D’Arpa D, Bongiorno A, et al. Oxidative stress after moderate to extensive burning in humans. Free Radic Res. 2000;33:139-46.
  • Sener G, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yeğen BC. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 2005;31:587-96.
  • Sener G, Sehirli AO, Gedik N, Dülger GA. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns 2007;33:587-93.
  • Koksel O, Ozdulger A, Tamer L, Cinel L, Ercil M, De- girmenci U, et al. Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats. Pulm Pharmacol Ther 2006;19:90-5.
  • Koksel O, Kaplan MB, Ozdulger A, Tamer L, Degirmenci U, Cinel L, et al. Oleic acid-induced lung injury in rats and effects of caffeic acid phenethyl ester. Exp Lung Res 2005;31:483-96.
  • Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L, Araya J. Changes in (Na + K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxica- tion. Chest 2002;121:589-96.
  • Furst DE. Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis. Clin Exp Rheuma- tol 2010;28(3 Suppl 59):S5-12.
  • Di Paola R, Mazzon E, Muià C, Crisafulli C, Terrana D, Greco S, et al. Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol 2007;150:286-97.
Toplam 40 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Makaleler
Yazarlar

Ahmet Şehirli

Burcu Ünlü

Şule Çetinel

Şermin Tetik

Emre Şener

Göksel Şener

Yayımlanma Tarihi 7 Mart 2014
Yayımlandığı Sayı Yıl 2011 Cilt: 15 Sayı: 3

Kaynak Göster

APA Şehirli, A., Ünlü, B., Çetinel, Ş., Tetik, Ş., vd. (2014). Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharmaceutical Journal, 15(3), 118-124. https://doi.org/10.12991/mpj.14363
AMA Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G. Etanercept protects remote organ damage in a rat model of thermal injury. J Res Pharm. Mart 2014;15(3):118-124. doi:10.12991/mpj.14363
Chicago Şehirli, Ahmet, Burcu Ünlü, Şule Çetinel, Şermin Tetik, Emre Şener, ve Göksel Şener. “Etanercept Protects Remote Organ Damage in a Rat Model of Thermal Injury”. Marmara Pharmaceutical Journal 15, sy. 3 (Mart 2014): 118-24. https://doi.org/10.12991/mpj.14363.
EndNote Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G (01 Mart 2014) Etanercept protects remote organ damage in a rat model of thermal injury. Marmara Pharmaceutical Journal 15 3 118–124.
IEEE A. Şehirli, B. Ünlü, Ş. Çetinel, Ş. Tetik, E. Şener, ve G. Şener, “Etanercept protects remote organ damage in a rat model of thermal injury”, J Res Pharm, c. 15, sy. 3, ss. 118–124, 2014, doi: 10.12991/mpj.14363.
ISNAD Şehirli, Ahmet vd. “Etanercept Protects Remote Organ Damage in a Rat Model of Thermal Injury”. Marmara Pharmaceutical Journal 15/3 (Mart 2014), 118-124. https://doi.org/10.12991/mpj.14363.
JAMA Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G. Etanercept protects remote organ damage in a rat model of thermal injury. J Res Pharm. 2014;15:118–124.
MLA Şehirli, Ahmet vd. “Etanercept Protects Remote Organ Damage in a Rat Model of Thermal Injury”. Marmara Pharmaceutical Journal, c. 15, sy. 3, 2014, ss. 118-24, doi:10.12991/mpj.14363.
Vancouver Şehirli A, Ünlü B, Çetinel Ş, Tetik Ş, Şener E, Şener G. Etanercept protects remote organ damage in a rat model of thermal injury. J Res Pharm. 2014;15(3):118-24.

.